Moiz Diwan Headshot

Moiz Diwan

Moiz Diwan is a director within the Process Research and Development organization at AbbVie. Moiz has led early to late-stage pharmaceutical development teams involving drug substance control strategy development, establishing global supply chain, process tech-transfer and scale-up, and authored global regulatory filings for 1st Gen. HCV Viekira and HCV Next Gen. Mavyret drugs.

 

Presently, Moiz is leading Center of Excellence, a cross functional team of chemists, engineers and PAT scientists focusing on fundamentals‐driven process development through application of enabling technologies, data rich experimentation, and predictive modeling. This center has supported commercial process development and regulatory submissions for 5 commercial drugs and >50 clinical assets in last 4 years. Moiz also built from ground-up FAST – Flow and Automation Strategy Team at AbbVie. FAST is a multi-disciplinary team of scientists and engineers from 6+ AbbVie sites across Discovery, Development, and Operations Manufacturing organization to efficiently share capabilities and resources, facilitate collaboration and provide strategic advancement on lab automation, plant automation, information management and continuous manufacturing technologies to maximize the impact. Moiz is passionate about people, building and sustaining high performance organizations, continuous learning, and translating science and innovation into products that make a difference to human health.

 

Moiz has captured his scientific contribution in over 50 journal publications, patents, book chapters, invited seminars and conference presentations. Moiz is board member of AIChE PD2M committee, editorial advisory board for CEP magazine and board member of Purdue Chemical Engineering Industrial Advisory Committee. Moiz was Programming chair for PD2M division of 2020 AIChE Annual Meeting. Moiz won 2021 AIChE Young Leader award for outstanding leadership and impact to the practice of Chemical Engineering. At AbbVie, Moiz is recipient of President Award, AbbVie Volwiler Scientific Society Outstanding Team Award and multiple Excellence Awards for global regulatory submissions and Launch of HCV Viekira Pak and NXT Gen. Mavyret. Moiz completed his M.S. and PhD degree from Purdue University in Chemical engineering and bachelor’s degree from Indian Institute of Technology in Chemical Engineering.

[BACK]